ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin-Reference-Cited by-同舟云学术

ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin

Published:2022-11-06 Issue:3 Volume:30 Page:1870-1871
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

El Asmar Antoine^ORCID,Liberale Gabriel

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-022-12771-y.pdf

Reference5 articles.

1. Alyami M, Kim BJ, Villeneuve L, et al. Ninety-day post-operative morbidity and mortality using the National Cancer Institute’s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2017;34(5):532–7. https://doi.org/10.1080/02656736.2017.1367846.

2. Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a Multicentric French Study From the Institut. J Clin Oncol. 2009;28:63–8. https://doi.org/10.1200/JCO.2009.23.9285.

3. Zager Y, Hoffman A, Dreznik Y, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios. Surg Oncol. 2020;35:321–7. https://doi.org/10.1016/J.SURONC.2020.09.002.

4. Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis. J Natl Cancer Inst. 2014. https://doi.org/10.1093/jnci/dju124.

5. El Asmar A, Delcourt M, Kamden L, et al. Prognostic value of preoperative serological biomarkers in patients undergoing curative-intent cytoreductive surgery for colorectal cancer peritoneal metastases. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12736-1